Microbix Biosystems Inc.

TSX (CAD): Microbix Biosystems Inc. (MBX)

Last Price

0.495

Today's Change

-0.005 (1.01%)

Day's Change

0.49 - 0.495

Trading Volume

51,373

Overview

Market Cap

66 Million

Shares Outstanding

134 Million

Avg Volume

144,409

Avg Price (50 Days)

0.41

Avg Price (200 Days)

0.35

PE Ratio

16.50

EPS

0.03

Earnings Announcement

13-Feb-2025

Previous Close

0.49

Open

0.49

Day's Range

0.49 - 0.495

Year Range

0.29 - 0.52

Trading Volume

51,373

Price Change Highlight

1 Day Change

-1.01%

5 Day Change

6.45%

1 Month Change

15.12%

3 Month Change

54.69%

6 Month Change

54.69%

Ytd Change

22.22%

1 Year Change

25.32%

3 Year Change

-25.00%

5 Year Change

106.25%

10 Year Change

-21.43%

Max Change

-32.19%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment